Aurobindo Pharma

Aurobindo Pharma Ltd., is a Leading Pharmaceutical company having 23 plants worldwide with regulatory approvals from USFDA, UK MHRA etc. with a turnover of more than $2.5 billion dollars.

Aurobindo Pharma Ltd., is a Leading Pharmaceutical company having 23 plants worldwide with regulatory approvals from USFDA, UK MHRA etc. with a turnover of more than $2.5 billion dollars.

Aurobindo Pharma Ltd., is a Leading Pharmaceutical company having 23 plants worldwide with regulatory approvals from USFDA, UK MHRA etc. with a turnover of more than $2.5 billion dollars.

Aurobindo Pharma has identified international operations, catering to over 100 countries, as a major engine of growth and expanding global network of marketing and manufacturing operations across countries like China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, Russia, Netherlands and many more which will further expand its international reach.

Aurobindo Pharma has identified international operations, catering to over 100 countries, as a major engine of growth and expanding global network of marketing and manufacturing operations across countries like China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, Russia, Netherlands and many more which will further expand its international reach.

Aurobindo Pharma has identified international operations, catering to over 100 countries, as a major engine of growth and expanding global network of marketing and manufacturing operations across countries like China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, Russia, Netherlands and many more which will further expand its international reach.

Aurobindo Pharma Ltd., is a Leading Pharmaceutical company having 23 plants worldwide with regulatory approvals from USFDA, UK, MHRA etc. with a turnover of more than $2.5 billion dollars. Aurobindo Pharma has identified international operations, catering to over 100 countries, as a major engine of growth and expanding global network of marketing and manufacturing operations across countries like China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, Russia, Netherlands and many more which will further expand its international reach.

A leading pharmaceutical company having 23 plants woridwide with regulatory approvals from USFDA, UK, MHRA, etc., with a turnover of more than $2.5 billion, invites applications for the following positions for its automated and most modem Injectable Formulation Units located at Hyderabad and Jedcherta (SEZ) to meet the existing and expansion requirements.